Parecoxib is a COX2 selective inhibitor in the same category as celecoxib and rofecoxib. As it is injectable, it can be used perioperatively when patients are unable to take oral medications. Parecoxib is a water-soluble and injectable prodrug of valdecoxib. Reference standards of Parecoxib Sodium API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Parecoxib Sodium
Catalogue No.:PA 69 18000
CAS :
Molecular Formula : C19H17N2NaO4S
Molecular Weight : 392.40
Parecoxib-d5 Sodium
Catalogue No.:PA STI 071500
Molecular Formula : C19H12D5N2NaO4S
Molecular Weight : 397.43
N,N'-((5-Methylisoxazole-3,4-diyl)bis(4,1-phenylenesulfonyl))dipropionamide
Catalogue No.:PA 69 18510
Molecular Formula : C22H23N3O7S2
Molecular Weight : 505.56
N-((4-(5-Methyl-3-(2-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide
Catalogue No.:PA 69 18520
N-((3-(5-Methyl-3-(4-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide
Catalogue No.:PA 69 18530
N,N'-((5-Methylisoxazole-3,4-diyl)bis(3,1-phenylenesulfonyl))dipropionamide
Catalogue No.:PA 69 18540
N-((3-(5-Methyl-3-(2-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide
Catalogue No.:PA 69 18550
N-((2-(5-Methyl-3-(4-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide
Catalogue No.:PA 69 18560
N-((2-(5-Methyl-3-(3-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide
Catalogue No.:PA 69 18570
N,N'-((5-Methylisoxazole-3,4-diyl)bis(2,1-phenylenesulfonyl))dipropionamide
Catalogue No.:PA 69 18580
N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]acetamide
Catalogue No.:PA 69 0181001
Molecular Formula : C18H16N2O4S
Molecular Weight : 356.4
Sodium acetyl((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)amide
Catalogue No.:PA 69 0181002
Molecular Formula : C18H15N2NaO4S
Molecular Weight : 378.38
Sodium ((4-(3-phenyl-6H-1,2-oxazin-4-yl)phenyl)sulfonyl)(propionyl)amide
Catalogue No.:PA 69 0181003
Molecular Weight : 392.4
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
